跳至主要内容
临床试验/NCT07129395
NCT07129395进行中(未招募)不适用

Optimizing Measurement of Anticoagulation Adherence

Children's Hospital Medical Center, Cincinnati1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年1月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
30
试验地点
1
主要终点
Measure adherence via electronic adherence monitoring device (EAMD)

研究概览

简要总结

Single center study to evaluate the feasibility of using 3 different strategies to measure adherence among children, adolescents, and young adults prescribed an anticoagulation medication

详细描述

This is an observational study with a maximum of 5 study visits during the 12-week study period. The study visit schedule has been designed to align with current clinical care practices. Adherence will be assessed via the EAMDs device, as well as by self-report measure in the BAT and by staff telephone inquiry regarding pharmacy refill data. Adherence data will be used to compute rates and trajectories of adherence to anticoagulants.

It is anticipated that this study will conclude in approximately 2 years, including data analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
— 至 29 Years(Child, Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Anticoagulated CCHMC patients ages 0 to 29.9 years and their caregivers (where applicable for patients < 18 years)
  • •Able to provide informed consent
  • •Duration of anticoagulation planned for the outpatient setting is 4 weeks or longer
  • •Willing and able to participate in telephone and in person study visits
  • •For patients < 18 years, both patient and caregiver agree to participate

排除标准

  • •Unwilling or unable to provide informed consent
  • •Duration of anticoagulation is planned for < 4 weeks in the outpatient setting
  • •Anticoagulant drug will not fit into the EAMD
  • •Unable to participate in telephone study visit

结局指标

主要结局

Measure adherence via electronic adherence monitoring device (EAMD)

时间窗: 12 weeks

Participants will be provided with a MEMS® Cap if they are prescribed an oral medication and a MEMS® Injectable if they are prescribed an injectable medication. Patients and families will then be trained by study nurse coordinator (NC) or principal investigator (PI) regarding how to use the MEMS® for medication administration throughout the study.

次要结局

  • Self-reported barriers to adherence.(12 weeks)
  • Rate barriers to adherence.(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验